Frontiers in Pharmacology | Pharmacogenetics and Pharmacogenomics

Original Research

Published on 06 Nov 2020

Risperidone-Induced Obesity in Children and Adolescents With Autism Spectrum Disorder: Genetic and Clinical Risk Factors

in Pharmacogenetics and Pharmacogenomics

Natchaya Vanwong
Nattawat Ngamsamut
Nopphadol Nuntamool
Yaowaluck Hongkaew
Rattanaporn Sukprasong
Apichaya Puangpetch
Penkhae Limsila
Chonlaphat Sukasem

Frontiers in Pharmacology

doi 10.3389/fphar.2020.565074

7,479 views
15 citations

Original Research

Published on 29 Oct 2020

Identification of Mutations Related to Cisplatin-Resistance and Prognosis of Patients With Lung Adenocarcinoma

in Pharmacogenetics and Pharmacogenomics

Rui Li
Junfang Liu
Zekui Fang
Zhenyu Liang
Xin Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2020.572627

5,130 views
12 citations

Editorial

Published on 07 Oct 2020

Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response

in Pharmacogenetics and Pharmacogenomics

Gloria Ravegnini
Marzia Del Re
Ambra A. Grolla
Ron H. N. van Schaik
Sabrina Angelini

Frontiers in Pharmacology

doi 10.3389/fphar.2020.598261

2,023 views

Systematic Review

Published on 06 Oct 2020

Genetic Variants in DNA Repair Pathways as Potential Biomarkers in Predicting Treatment Outcome of Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: A Systematic Review

in Pharmacogenetics and Pharmacogenomics

Emma C. Hulshof
Lifani Lim
Ignace H. J. T. de Hingh
Hans Gelderblom
Henk-Jan Guchelaar
Maarten J. Deenen

Frontiers in Pharmacology

doi 10.3389/fphar.2020.577968

3,573 views
4 citations

Systematic Review

Published on 23 Sep 2020

Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines

in Pharmacogenetics and Pharmacogenomics

Lisanne E. N. Manson
Jesse J. Swen
Henk-Jan Guchelaar

Frontiers in Pharmacology

doi 10.3389/fphar.2020.567048

15,831 views
38 citations

Original Research

Published on 16 Sep 2020

Outcomes and Laboratory and Clinical Findings of Asthma and Allergic Patients Admitted With Covid-19 in a Spanish University Hospital

in Pharmacogenetics and Pharmacogenomics

Jesús Miguel García-Menaya
Concepción Cordobés-Durán
Juan Francisco Rangel-Mayoral
Elena García-Martín
José A. G. Agúndez

Frontiers in Pharmacology

doi 10.3389/fphar.2020.570721

4,637 views
6 citations

Mini Review

Published on 11 Sep 2020

Pharmacogenetics in Psychiatry: An Update on Clinical Usability

in Pharmacogenetics and Pharmacogenomics

Ron H. N. van Schaik
Daniel J. Müller
Alessandro Serretti
Magnus Ingelman-Sundberg

Frontiers in Pharmacology

doi 10.3389/fphar.2020.575540

32,029 views
62 citations

Original Research

Published on 09 Sep 2020

Sickle Cell Anemia: Variants in the CYP2D6, CAT, and SLC14A1 Genes Are Associated With Improved Hydroxyurea Response

in Pharmacogenetics and Pharmacogenomics

Sètondji Cocou Modeste Alexandre Yahouédéhou
Joelma Santana dos Santos Neres
Caroline Conceição da Guarda
Suellen Pinheiro Carvalho
Rayra Pereira Santiago
Camylla Vilas Boas Figueiredo
Luciana Magalhães Fiuza
Uche Samuel Ndidi
Rodrigo Mota de Oliveira
Cleverson Alves Fonseca

Frontiers in Pharmacology

doi 10.3389/fphar.2020.553064

5,047 views
8 citations

Data Report

Published on 02 Sep 2020

COVIEdb: A Database for Potential Immune Epitopes of Coronaviruses

in Pharmacogenetics and Pharmacogenomics

Jingcheng Wu
Wenfan Chen
Jingjing Zhou
Wenyi Zhao
Yisheng Sun
Hanping Zhu
Pingping Yao
Shuqing Chen
Jianmin Jiang
Zhan Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2020.572249

5,278 views
15 citations

Editorial

Published on 14 Aug 2020

Editorial: Pharmacogenetics Research and Clinical Applications: An International Landscape of the Accomplishments, Challenges, and Opportunities

in Pharmacogenetics and Pharmacogenomics

Nathalie K. Zgheib
George P. Patrinos

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01217

2,390 views
5 citations

Original Research

Published on 14 Aug 2020

Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients?

in Pharmacogenetics and Pharmacogenomics

Michal Walczak
Liliana Lykowska-Szuber
Marianna Plucinska
Kamila Stawczyk-Eder
Oliwia Zakerska-Banaszak
Piotr Eder
Iwona Krela-Kazmierczak
Michal Michalak
Marek Zywicki
Wojciech M. Karlowski

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01207

4,158 views
7 citations

Editorial

Published on 13 Aug 2020

Editorial: Big Data, Pharmacogenomics and Real-World Research in Pharmacology

in Pharmacogenetics and Pharmacogenomics

James Cheng-Chung Wei
Wei-Chiao Chang
Taisei Mushiroda

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01239

3,781 views
3 citations

Original Research

Published on 12 Aug 2020

Analysis of Drug Metabolizing Gene Panel in Osteosarcoma Patients Identifies Association Between Variants in SULT1E1, CYP2B6 and CYP4F8 and Methotrexate Levels and Toxicities

in Pharmacogenetics and Pharmacogenomics

Evelien G. E. Hurkmans
Marije J. Klumpers
Sita H. Vermeulen
Melanie M. Hagleitner
Uta Flucke
H. W. Bart Schreuder
Hans Gelderblom
Johannes Bras
Henk-Jan Guchelaar
Marieke J. H. Coenen

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01241

3,111 views
10 citations

Original Research

Published on 11 Aug 2020

CYP3A5 Gene-Guided Tacrolimus Treatment of Living-Donor Egyptian Kidney Transplanted Patients

in Pharmacogenetics and Pharmacogenomics

Effrosyni Mendrinou
Mohamed Elsayed Mashaly
Amir Mohamed Al Okily
Mohamed Elsayed Mohamed
Ayman Fathi Refaie
Essam Mahmoud Elsawy
Hazem Hamed Saleh
Hussein Sheashaa
George P. Patrinos

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01218

5,722 views
17 citations

Review

Published on 05 Aug 2020

Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology

in Pharmacogenetics and Pharmacogenomics

Emma C. Bernsen
Melanie M. Hagleitner
Theodorus W. Kouwenberg
Lidwien M. Hanff

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01184

7,433 views
10 citations

Original Research

Published on 04 Aug 2020

CYP2D6 Genotype-Based Dose Recommendations for Risperidone in Asian People

in Pharmacogenetics and Pharmacogenomics

Yuanxia Cui
Hao Yan
Yi Su
Lifang Wang
Tianlan Lu
Dai Zhang
Weihua Yue

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00936

10,824 views
13 citations

Navigation group

Articles

Risperidone-Induced Obesity in Children and Adolescents With Autism Spectrum Disorder: Genetic and Clinical Risk Factors

Identification of Mutations Related to Cisplatin-Resistance and Prognosis of Patients With Lung Adenocarcinoma

Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response

Genetic Variants in DNA Repair Pathways as Potential Biomarkers in Predicting Treatment Outcome of Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: A Systematic Review

Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines

Outcomes and Laboratory and Clinical Findings of Asthma and Allergic Patients Admitted With Covid-19 in a Spanish University Hospital

Pharmacogenetics in Psychiatry: An Update on Clinical Usability

Sickle Cell Anemia: Variants in the CYP2D6, CAT, and SLC14A1 Genes Are Associated With Improved Hydroxyurea Response

COVIEdb: A Database for Potential Immune Epitopes of Coronaviruses

Editorial: Pharmacogenetics Research and Clinical Applications: An International Landscape of the Accomplishments, Challenges, and Opportunities

Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients?

Editorial: Big Data, Pharmacogenomics and Real-World Research in Pharmacology

Analysis of Drug Metabolizing Gene Panel in Osteosarcoma Patients Identifies Association Between Variants in SULT1E1, CYP2B6 and CYP4F8 and Methotrexate Levels and Toxicities

CYP3A5 Gene-Guided Tacrolimus Treatment of Living-Donor Egyptian Kidney Transplanted Patients

Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology

CYP2D6 Genotype-Based Dose Recommendations for Risperidone in Asian People